AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
PROSTAGLANDIN E-2 INCREASES BONE STRENGTH IN INTACT RATS AND IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA
Authors: KE HZ SHEN VW QI H CRAWFORD DT WU DD LIANG XG CHIDSEYFRINK KL PIRIE CM SIMMONS HA THOMPSON DD
Citation: Hz. Ke et al., PROSTAGLANDIN E-2 INCREASES BONE STRENGTH IN INTACT RATS AND IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Bone (New York, N.Y.), 23(3), 1998, pp. 249-255
CONCURRENT TRICHINOSIS AND ORAL SQUAMOUS-CELL CARCINOMA IN A CAT
Authors: MOISAN PG LORENZ MD STROMBERG PC SIMMONS HA
Citation: Pg. Moisan et al., CONCURRENT TRICHINOSIS AND ORAL SQUAMOUS-CELL CARCINOMA IN A CAT, Journal of veterinary diagnostic investigation, 10(2), 1998, pp. 199-202
PARATHYROID-HORMONE-(1-34) INCREASED TOTAL-BODY BONE MASS IN AGED FEMALE RATS
Authors: SIMMONS HA PIRIE CM THOMPSON DD KE HZ
Citation: Ha. Simmons et al., PARATHYROID-HORMONE-(1-34) INCREASED TOTAL-BODY BONE MASS IN AGED FEMALE RATS, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 341-344
DISCOVERY AND PRECLINICAL PHARMACOLOGY OF A NOVEL, POTENT, NONSTEROIDAL ESTROGEN-RECEPTOR AGONIST ANTAGONIST, CP-336156, A DIARYLTETRAHYDRONAPHTHALENE/
Authors: ROSATI RL JARDINE PD CAMERON KO THOMPSON DD KE HZ TOLER SM BROWN TA PAN LC EBBINGHAUS CF REINHOLD AR ELLIOTT NC NEWHOUSE BN TJOA CM SWEETNAM PM COLE MJ ARRIOLA MW GAUTHIER JW CRAWFORD DT NICKERSON DF PIRIE CM QI H SIMMONS HA TKALCEVIC GT
Citation: Rl. Rosati et al., DISCOVERY AND PRECLINICAL PHARMACOLOGY OF A NOVEL, POTENT, NONSTEROIDAL ESTROGEN-RECEPTOR AGONIST ANTAGONIST, CP-336156, A DIARYLTETRAHYDRONAPHTHALENE/, Journal of medicinal chemistry, 41(16), 1998, pp. 2928-2931
EFFECTS OF CP-336,156, A NEW, NONSTEROIDAL ESTROGEN AGONIST ANTAGONIST, ON BONE, SERUM-CHOLESTEROL, UTERUS, AND BODY-COMPOSITION IN RAT MODELS/
Authors: KE HZ PARALKAR VM GRASSER WA CRAWFORD DT QI H SIMMONS HA PIRIE CM CHIDSEYFRINK KL OWEN TA SMOCK SL CHEN HK JEE WSS CAMERON KO ROSATI RL BROWN TA DASILVAJARDINE P THOMPSON DD
Citation: Hz. Ke et al., EFFECTS OF CP-336,156, A NEW, NONSTEROIDAL ESTROGEN AGONIST ANTAGONIST, ON BONE, SERUM-CHOLESTEROL, UTERUS, AND BODY-COMPOSITION IN RAT MODELS/, Endocrinology, 139(4), 1998, pp. 2068-2076
COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN, AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT MODEL
Authors: KE HZ CHEN HK SIMMONS HA QI H CRAWFORD DT PIRIE CM CHIDSEYFRINK KL MA YF JEE WSS THOMPSON DD
Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN, AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT MODEL, Bone, 20(1), 1997, pp. 31-39
ESTROGEN RECEPTOR-ALPHA KNOCKOUT (ERKO) MICE LOSE TRABECULAR AND CORTICAL BONE FOLLOWING OVARIECTOMY
Authors: PAN LC KE HZ SIMMONS HA CRAWFORD DT CHIDSEYFRINK KL MCCURDY SP SCHAFER JR KIMBRO KS TAKI M KORACH KS THOMPSON DD
Citation: Lc. Pan et al., ESTROGEN RECEPTOR-ALPHA KNOCKOUT (ERKO) MICE LOSE TRABECULAR AND CORTICAL BONE FOLLOWING OVARIECTOMY, Journal of bone and mineral research, 12, 1997, pp. 126-126
DROLOXIFENE INCREASES BONE MASS IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA
Authors: KE HZ CHIDSEYFRINK KL QI H CRAWFORD DT PIRIE CM SIMMONS HA THOMPSON DD
Citation: Hz. Ke et al., DROLOXIFENE INCREASES BONE MASS IN OVARIECTOMIZED RATS WITH ESTABLISHED OSTEOPENIA, Journal of bone and mineral research, 12, 1997, pp. 494-494
PROSTAGLANDIN E-2 INCREASES MECHANICAL STRENGTH OF THE DISTAL FEMUR, FEMORAL-NECK, FEMORAL DIAPHYSIS AND LUMBAR VERTEBRAL BODY IN ADULT MALE-RATS
Authors: LIANG XG CRAWFORD DT CHIDSEYFRINK KL PIRIE CM SIMMONS HA THOMPSON DD SHEN V KE HZ
Citation: Xg. Liang et al., PROSTAGLANDIN E-2 INCREASES MECHANICAL STRENGTH OF THE DISTAL FEMUR, FEMORAL-NECK, FEMORAL DIAPHYSIS AND LUMBAR VERTEBRAL BODY IN ADULT MALE-RATS, Journal of bone and mineral research, 12, 1997, pp. 495-495
DROLOXIFENE DOES NOT BLUNT THE BONE ANABOLIC EFFECTS OF PROSTAGLANDINE(2) (PGE(2)) BUT MAINTAINS THE PGE(2)-RESTORED BONE IN OSTEOPENIC RATS
Authors: THOMPSON DD OI H CRAWFORD DT PIRIE CM SIMMONS HA KE HZ
Citation: Dd. Thompson et al., DROLOXIFENE DOES NOT BLUNT THE BONE ANABOLIC EFFECTS OF PROSTAGLANDINE(2) (PGE(2)) BUT MAINTAINS THE PGE(2)-RESTORED BONE IN OSTEOPENIC RATS, Journal of bone and mineral research, 11, 1996, pp. 1-1
CP-336,156, A HIGHLY POTENT ESTROGEN AGONIST ANTAGONIST, PREVENTS BONE LOSS, REDUCES TOTAL SERUM-CHOLESTEROL, BUT LACKS UTERINE STIMULATIVEEFFECT IN OVARIECTOMIZED RATS/
Authors: KE HZ CRAWFORD DT OI H CHIDSEYFRINK KL SIMMONS HA PIRIE CM CHEN HK JEE WSS ROSATI RL CAMERON KO TOLER SM JARDINE PD THOMPSON DD
Citation: Hz. Ke et al., CP-336,156, A HIGHLY POTENT ESTROGEN AGONIST ANTAGONIST, PREVENTS BONE LOSS, REDUCES TOTAL SERUM-CHOLESTEROL, BUT LACKS UTERINE STIMULATIVEEFFECT IN OVARIECTOMIZED RATS/, Journal of bone and mineral research, 11, 1996, pp. 251-251
DISCOVERY AND SAR OF A POTENT NONSTEROIDAL ESTROGEN AGONIST
Authors: ROSATI RL JARDINE PD CAMERON KO THOMPSON DD KE HZ TOLER SM BROWN TA PAN LC EBBINGHAUS CF REINHOLD AR ELLIOTT NC NEWHOUSE BN TJOA CM SWEETNAM PM COLE MJ ARRIOLA MW GAUTHIER JW CRAWFORD DT NICKERSON DF PIRIE C OI H SIMMONS HA TKALCEVIC GT
Citation: Rl. Rosati et al., DISCOVERY AND SAR OF A POTENT NONSTEROIDAL ESTROGEN AGONIST, Journal of bone and mineral research, 11, 1996, pp. 591-591
CONTRASTING RESPONSES OF 2 TRANSGENIC MOUSE LINES TO PARATHYROID-HORMONE AND PROSTAGLANDIN-E(2)
Authors: MCCURDY SP MICLETTE LB SIMMONS HA THOMPSON DD PAN LC
Citation: Sp. Mccurdy et al., CONTRASTING RESPONSES OF 2 TRANSGENIC MOUSE LINES TO PARATHYROID-HORMONE AND PROSTAGLANDIN-E(2), Journal of bone and mineral research, 11, 1996, pp. 614-614
SPECIES AND INDIVIDUAL VARIATIONS IN CRYOPROTECTANT TOXICITIES AND FREEZING RESISTANCES OF EPIDIDYMAL SPERM FROM AFRICAN ANTELOPE
Authors: LOSKUTOFF NM SIMMONS HA GOULDING M THOMPSON G DEJONGH T SIMMONS LG
Citation: Nm. Loskutoff et al., SPECIES AND INDIVIDUAL VARIATIONS IN CRYOPROTECTANT TOXICITIES AND FREEZING RESISTANCES OF EPIDIDYMAL SPERM FROM AFRICAN ANTELOPE, Animal reproduction science, 42(1-4), 1996, pp. 527-535
EFFECTS OF DROLOXIFENE ON PREVENTION OF CANCELLOUS BONE LOSS AND BONETURNOVER IN THE AXIAL SKELETON OF AGED, OVARIECTOMIZED RATS
Authors: KE HZ CHEN HK QI H PIRIE CM SIMMONS HA MA YF JEE WSS THOMPSON DD
Citation: Hz. Ke et al., EFFECTS OF DROLOXIFENE ON PREVENTION OF CANCELLOUS BONE LOSS AND BONETURNOVER IN THE AXIAL SKELETON OF AGED, OVARIECTOMIZED RATS, Bone, 17(5), 1995, pp. 491-496
FDA GUIDELINES AND ANIMAL-MODELS FOR OSTEOPOROSIS
Authors: THOMPSON DD SIMMONS HA PIRIE CM KE HZ
Citation: Dd. Thompson et al., FDA GUIDELINES AND ANIMAL-MODELS FOR OSTEOPOROSIS, Bone, 17(4), 1995, pp. 125-133
DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS
Authors: CHEN HK ZE HZ LIN CH MA YF QI H CRAWFORD DT PIRIE CM SIMMONS HA JEE WSS THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS, Bone, 17(4), 1995, pp. 175-179
DROLOXIFENE PREVENTS OVARIECTOMY-INDUCED BONE LOSS IN TIBIAE AND FEMORA OF AGED FEMALE RATS - A DUAL-ENERGY X-RAY ABSORPTIOMETRIC AND HISTOMORPHOMETRIC STUDY
Authors: CHEN HK KE HZ JEE WSS MA YF PIRIE CM SIMMONS HA THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE PREVENTS OVARIECTOMY-INDUCED BONE LOSS IN TIBIAE AND FEMORA OF AGED FEMALE RATS - A DUAL-ENERGY X-RAY ABSORPTIOMETRIC AND HISTOMORPHOMETRIC STUDY, Journal of bone and mineral research, 10(8), 1995, pp. 1256-1262
COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT
Authors: KE HZ CRAWFORD DT SIMMONS HA PIRIE CM OI H THOMPSON DD
Citation: Hz. Ke et al., COMPARATIVE EFFECTS OF DROLOXIFENE, TAMOXIFEN AND ESTROGEN ON BONE, SERUM-CHOLESTEROL, AND UTERINE HISTOLOGY IN THE OVARIECTOMIZED RAT, Journal of bone and mineral research, 10, 1995, pp. 143-143
DROLOXIFENE PREVENTS CANCELLOUS BONE LOSS AND INHIBITS BONE TURNOVER IN THE FEMORAL-NECK OF OVARIECTOMIZED RATS
Authors: OI H KE HZ CRAWFORD DT PIRIE CM SIMMONS HA THOMPSON DD
Citation: H. Oi et al., DROLOXIFENE PREVENTS CANCELLOUS BONE LOSS AND INHIBITS BONE TURNOVER IN THE FEMORAL-NECK OF OVARIECTOMIZED RATS, Journal of bone and mineral research, 10, 1995, pp. 198-198
BONE CELL-DYNAMICS FOLLOWING MARROW ABLATION AND THE ROLE OF PROSTAGLANDINS
Authors: SIMMONS HA PIRIE CM GRASSER WA THOMPSON DD
Citation: Ha. Simmons et al., BONE CELL-DYNAMICS FOLLOWING MARROW ABLATION AND THE ROLE OF PROSTAGLANDINS, Journal of bone and mineral research, 10, 1995, pp. 307-307
DROLOXIFENE AND ESTROGEN IDENTICALLY INHIBIT OSTEOCLASTOGENESIS IN RAT BONE-MARROW CULTURES
Authors: GRASSER WA PAN LC SIMMONS HA SMOCK SL PIRIE CM THOMPSON DD
Citation: Wa. Grasser et al., DROLOXIFENE AND ESTROGEN IDENTICALLY INHIBIT OSTEOCLASTOGENESIS IN RAT BONE-MARROW CULTURES, Journal of bone and mineral research, 10, 1995, pp. 323-323
DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS
Authors: CHEN HK KE HZ LIN CH MA YF",OI,"QI H CRAWFORD DT SIMMONS HA PIRIE CM JEE WSS THOMPSON DD
Citation: Hk. Chen et al., DROLOXIFENE INHIBITS CORTICAL BONE TURNOVER ASSOCIATED WITH ESTROGEN DEFICIENCY IN RATS, Journal of bone and mineral research, 10, 1995, pp. 355-355
DROLOXIFENE, A NEW ESTROGEN ANTAGONIST AGONIST, PREVENTS BONE LOSS INOVARIECTOMIZED RATS
Authors: KE HZ SIMMONS HA PIRIE CM CRAWFORD DT THOMPSON DD
Citation: Hz. Ke et al., DROLOXIFENE, A NEW ESTROGEN ANTAGONIST AGONIST, PREVENTS BONE LOSS INOVARIECTOMIZED RATS, Endocrinology, 136(6), 1995, pp. 2435-2441
URINARY 3-ALPHA,17-BETA-ANDROSTANEDIOL GLUCURONIDE IS A MEASURE OF ANDROGENIC STATUS IN ELD DEER STAGS (CERVUS-ELDI-THAMIN)
Authors: MONFORT SL HARVEY E GEURTS L PADILLA L SIMMONS HA WILLIAMSON LR
Citation: Sl. Monfort et al., URINARY 3-ALPHA,17-BETA-ANDROSTANEDIOL GLUCURONIDE IS A MEASURE OF ANDROGENIC STATUS IN ELD DEER STAGS (CERVUS-ELDI-THAMIN), Biology of reproduction, 53(3), 1995, pp. 700-706
Risultati: 1-25 | 26-28